4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cutia Therapeutics (2487) operates in the Biotechnology industry and is headquartered in Shanghai, China with about 304 employees. Its market capitalization is roughly CNY 843 million. In the fiscal year ended 2025-12-31, 2487 reported CNY 336M in revenue and (CNY 340M) in net income.
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People's Republic of China and Hong Kong.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 336M | CNY 280M | CNY 138M | CNY 11M |
| Gross Profit | CNY 196M | CNY 144M | CNY 71M | CNY 8M |
| Operating Income (EBIT) | (CNY 291M) | (CNY 455M) | (CNY 527M) | (CNY 303M) |
| Net Income | (CNY 340M) | (CNY 434M) | (CNY 2.0B) | (CNY 556M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.4B | CNY 1.7B | CNY 1.4B | — |
| Total Liabilities | CNY 421M | CNY 418M | CNY 358M | CNY 2.7B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2487 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms